No products in the cart.
Return To ShopNo products in the cart.
Return To ShopNo products in the cart.
Return To Shopanabolicdirectplus.com
No products in the cart.
Return To ShopTirzepatide 10 mg Beligas is an innovative solution for individuals seeking effective weight management and improved glycemic control. This unique medication combines the power of dual receptor agonists to help users achieve their health goals more efficiently. By targeting key pathways in the body, Tirzepatide works to effectively lower blood glucose levels while promoting weight loss, making it an essential tool in the journey to a healthier lifestyle. With a competitive price of €216.00, this product is a reliable choice for those ready to take charge of their health.
Tirzepatide 10 mg Beligas offers a variety of benefits that make it a preferred choice for people looking to improve their weight management. Its dual-action formula not only addresses weight loss but also supports effective glycemic control, leading to overall better health. Here’s a closer look at some of the main advantages:
Incorporating Tirzepatide 10 mg Beligas into your health regimen can yield numerous long-term benefits that go beyond initial weight loss. One of the most notable is its ability to help maintain lower blood pressure levels, contributing to improved cardiovascular health over time. This dual GIP and GLP-1 receptor agonist is studied and monitored for its efficacy in managing blood glucose levels, ensuring a safer path towards wellness.
With a recommended dosage typically starting at 2.5 mg once weekly, Tirzepatide allows for flexibility in increasing the dosage based on user response and tolerability. Its active half-life of about five days means that you may enjoy consistent effects without the need for daily administration. As you continue your journey with Tirzepatide, you will likely observe lasting improvements in not only your weight and glycemic control but your overall quality of life, reinforcing your commitment to a healthier, more fulfilling lifestyle.
| Active substance | Tirzepatide |
|---|---|
| Active Half-Life | 5 days |
| Classification | Dual GIP and GLP-1 Receptor Agonist |
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring blood glucose levels and HbA1c |
| Also known as | LY3298176 |
| WAREHOUSE | USA Warehouse 2 |
| Blood pressure | May reduce blood pressure |
| Trade name | Mounjaro |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F), protect from light |
| Chemical name | Tirzepatide |
| Formula | C225H348N48O68 |
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonists |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 5 days |
| Dosage (medical) | Typically started at 2.5 mg once weekly, can be increased to 5 mg, 10 mg, or 15 mg once weekly depending on response and tolerability |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Improves glycemic control, promotes weight loss |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation |
| Use in sports | None, not used for performance enhancement |
| Manufacturer | Beligas – US |
€144.00
Select at least 2 products
to compare
Reviews
There are no reviews yet.